The personalized genomics industry  achieved a valuation of $11.0 billion in 2022 and is projected to reach $28.14 billion by 2032, displaying a Compound Annual Growth Rate (CAGR) of 11% throughout the forecast period. The primary drivers behind this market expansion include the growing demand for tailored medical care, the prevalence of chronic ailments, and advancements in genomics...